問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Health Research Institutes
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-11-01 - 2024-05-13
Condition/Disease
Advanced Solid Tumors
Test Drug
Erdafitinib
Participate Sites13Sites
Not yet recruiting2Sites
Recruiting5Sites
Terminated6Sites
2019-12-01 - 2022-12-31
Advanced Biliary Tract Cancer
OPDIVO
Participate Sites7Sites
Recruiting7Sites
2019-04-01 - 2022-12-31
non-squamous non-small cell lung cancer
Durvalumab、Tremelimumab
Participate Sites8Sites
Recruiting8Sites
Division of General Internal Medicine
全部
